The chemical construction of some marketed AMPs. For gramicidin D and teicoplanin, only the most ample components with the clinically used mixtures are proven. Clinical trials and preclinical studies are highlighted, exhibiting the efficacy of peptide vaccines in inducing an immune reaction, with the likely to further improve survival prices for